Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.55 is in line with its 5-year average of 8.91, around the middle of its 5-year range (5.05–19.09).
As of the fiscal period ended Tuesday, June 30, 2026. 28.17% above its 12-month average of 7.45.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.55.
CURRENT RATIO
9.55
CURRENT RATIO AVG TTM
7.45
CURRENT RATIO AVG 3Y
8.83
CURRENT RATIO AVG 5Y
8.91
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+28.17%
CURRENT VS 3Y AVG
+8.16%
CURRENT VS 5Y AVG
+7.16%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+154.74%
vs the sector median at left
Market Cap
$95.14M
Current Ratio
8.13
TTM Avg
8.55
3Y Avg
9.73
5Y Avg
13.44
Market Cap
$99.62M
Current Ratio
26.75
TTM Avg
10.50
3Y Avg
7.03
5Y Avg
10.82
Market Cap
$93.96M
Current Ratio
1.12
TTM Avg
0.73
3Y Avg
0.59
5Y Avg
0.59
Market Cap
$102.75M
Current Ratio
8.54
TTM Avg
8.31
3Y Avg
10.99
5Y Avg
13.36
Market Cap
$103.14M
Current Ratio
7.28
TTM Avg
6.67
3Y Avg
7.13
5Y Avg
10.02
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korro Bio, Inc. (KRRO) | $97.14M | 9.55 | 7.45 | 8.83 | 8.91 |
| PolyPid Ltd. (PYPD)vs › | $97.90M | 1.35 | 1.64 | 1.44 | 4.41 |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | 8.13 | 8.55 | 9.73 | 13.44 |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | 26.75 | 10.50 | 7.03 | 10.82 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.96M | 1.12 | 0.73 | 0.59 | 0.59 |
| The Joint Corp. (JYNT)vs › | $101.36M | 1.83 | 1.56 | 1.30 | 1.30 |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | 8.54 | 8.31 | 10.99 | 13.36 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | 7.28 | 6.67 | 7.13 | 10.02 |
| Rallybio Corporation (RLYB)vs › | $90.64M | 27.26 | 12.68 | 13.62 | 17.71 |
Current Ratio
9.55
Quick Ratio
9.55
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.55 |
| 2026-03-31 | 8.13 |
| 2025-12-31 | 6.90 |
| 2025-09-30 | 6.71 |
| 2025-06-30 | 5.98 |
| 2025-03-31 | 9.41 |
| 2024-12-31 | 8.79 |
| 2024-09-30 | 11.23 |
| 2024-06-30 | 13.28 |
| 2024-03-31 | 13.18 |
| 2023-12-31 | 8.87 |
| 2023-09-30 | 5.15 |
| 2023-06-30 | 7.65 |
| 2023-03-31 | 9.15 |
| 2022-12-31 | 6.56 |
| 2022-09-30 | 5.05 |
| 2022-06-30 | 6.77 |
| 2022-03-31 | 9.85 |
| 2021-12-31 | 11.79 |
| 2021-09-30 | 14.30 |
| 2021-06-30 | 19.09 |
| 2021-03-31 | 10.58 |
| 2020-12-31 | 8.45 |
| 2020-09-30 | 6.91 |
| 2020-06-30 | 4.82 |
| 2020-03-31 | 4.80 |
| 2019-12-31 | 4.19 |
| 2019-09-30 | 2.31 |
